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Background. The literature on colorectal cancer (CRC) screening is contradictory regarding the impact of weight status on CRC
screening. This study was intended to determine if CRC screening rates among 2005 National Health Interview Survey (NHIS)
respondent racial/ethnic and gender subgroups were influenced by weight status. Methods. Univariable and multivariable logistic
regression analyses were performed to determine if CRC screening use diﬀered significantly among obese, overweight, and normal-
weight individuals in race/ethnic and gender subgroups. Results. Multivariable analyses showed that CRC screening rates did not
diﬀer significantly for individuals within these subgroups who were obese or overweight as compared to their normal-weight peers.
Conclusion. Weight status does not contribute to disparities in CRC screening in race/ethnicity and gender subgroups.
1. Introduction
Colorectal cancer (CRC) is highly preventable with screen-
ing, yet it remains the third leading cause of cancer death in
both men and women [1]. CRC screening is uniformly rec-
ommended in men and women as well as blacks and whites
over the age of 50. However, almost half of eligible individu-
als do not complete CRC screening within the recommended
interval [2]. Compared to non-Hispanic whites, Hispanics
and blacks are less likely to have had a CRC screening test [3].
Gender and weight status have also been reported to aﬀect
CRC screening. Obese individuals have higher morbidity
and mortality for many cancers including colorectal cancer
(CRC) [4, 5]. Currently, there is controversy about the
contributions of weight status, race/ethnicity, and gender to
observed CRC screening rates.
The literature on CRC screening and weight status in
large, nationally representative samples is contradictory. In
the 1997 Cancer Prevention Nutrition cohort, Chao et al.
observed lower rates of CRC screening in overweight men,
overweight women, obese men, and obese women in com-
parison to their normal weight peers [6]. In an analysis of
the 1999 Behavioral Risk Factor Surveillance Survey (BRFSS)
data, Rosen and Schneider found no diﬀerence in overall
CRC screening, endoscopy screening, or FOBT screening
among men regardless of weight status, but these authors
observed that morbidly obese women had a lower rate of
overall screening, endoscopy, and FOBT [7]. In 2001, another
study using BRFSS data reported that men who were over-
weight or obese (class I) were more likely to have undergone
endoscopic screening, while obese women (class I and II)
were less likely to have screened endoscopically [8]. Obesity
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had no eﬀect on fecal occult blood testing (FOBT) in either
gender [8].
In the 2000 National Health Interview survey (NHIS)
data, Wee et al. found a trend towards increased screening in
the overweight population compared to their normal weight
counterparts, but this analysis did not examine obesity and
overweight separately in relation to CRC screening, nor
did the analysis address the relationship of race/ethnicity
and gender with screening [9]. Using the 2005 NHIS data
set, Leone et al. reported lower screening in obese white
women compared to survey respondents who were not obese
(overweight and normal weight). However, they did not find
a similar association among black women [10]. That analysis
did not report on men or Hispanics and did not assess
the independent eﬀects of overweight and normal weight
status on screening. In a recent report that used Medicare
claims data and Veterans Health Administration data, Chang
et al. reported that obesity and overweight status had no sta-
tistically significant impact on CRC screening [11]. Although
that study provided insight into the impact of weight
status, the analysis did not separately examine the eﬀects
of race/ethnicity and gender. Many smaller studies have
examined this relationship but did control for other variables
known to influence CRC screening, such as socioeconomic
status, physician recommendation, and access to care.
This paper seeks to address limitations of prior analyses
by examining race/ethnicity and gender, along with weight
status, in CRC screening. This analysis uniquely includes
Hispanics and reports weight status in terms of normal, over-
weight, and obese. Thus, findings presented here provide a
more comprehensive view of factors which may impact CRC
screening use than has been reported in the literature to date
[7–10].
2. Materials and Methods
This study analyzed the data from the 2005 National Health
Interview Survey, a nationally representative, cross-sectional,
household survey of the civilian noninstitutionalized popu-
lation of the United States [12].
2.1. Participants. NHIS respondents in this study were indi-
viduals aged 50 to 80 years old [13]. We excluded individuals
who had missing data on weight status and covariates (n =
6392) as well as underweight (BMI ≤ 18.5) individuals
(n = 108). Based on an NHIS recoded variable, we
selected those individuals who self-identified as white (non-
Hispanic), black, or Hispanic.
The sampling plan follows a multistage area probability
design that permits the representative sampling of house-
holds and noninstitutional group quarters (e.g., college dor-
mitories) and oversamples of blacks, Hispanics, and Asians.
This complex survey design allows for population estimates
of the United States [12].
2.2. Dependent Variables
2.2.1. Colorectal Cancer Screening. We examined the self-
reported variables related to endoscopy and stool blood
testing and test date. The outcome variable of overall CRC
screening status (up to date or not) was defined as up to
date in individuals who had one of the following screening
tests: colonoscopy within the last 10 years, sigmoidoscopy in
last 5 years, or FOBT within the last year [13]. We required
a person to have complete answers to at least one of the
aforementioned screening test questions.
2.3. Independent Variables
2.3.1. Weight Status. Obesity was defined according to BMI
which was calculated as weight in kilograms divided by the
square of height in meters. BMI was categorized as under-
weight (<18.5), normal weight (18.5–24.9), overweight (25–
29.9), and obesity (≥30) [14]. When possible, obese weight
status was subdivided into BMI 30–34.9 (Class I), BMI 35–
39.9 (Class II), and BMI ≥ 40 (Class III).
2.4. Covariates. We examined the potential confounding
variables of age (50–59, 60–69, 70–79), marital status (mar-
ried, unmarried), education (<12 y, high school graduate,
some college, college graduate), annual income (<20K,
>20K), regular source of medical care (yes/no), insurance
status (yes/no), oﬃce visits in the last year (none, 1, 2–5,≥6),
personal history of cancer (yes/no), alcohol consumption
(heavy, light, none), health status (fair/poor, excellent/good),
smoking status (current, former, never), physician recom-
mendation (yes/no), number of comorbidities (0, 1, 2-3, 4-5,
6 or more), and physical recreational activity as metabolic
equivalents per week (none, <675mets, ≥675mets).
2.5. Statistical Analysis. In univariable analyses, we com-
puted the proportion of subjects who had CRC screening
across levels of each of the variables listed above (and shown
in Table 1), as well as associated unadjusted odds ratios. We
then fit twomultivariable logistic regressionmodels. The first
model included main eﬀects for all the variables shown in
Table 1 and yielded adjusted odds ratios. The second model
included the same main eﬀects, as well as interaction terms
for gender by race/ethnicity, gender by weight status, and
race/ethnicity by weight status, which allowed us to assess
whether either gender or race/ethnicity modified the associ-
ation between weight status and CRC screening. All logistic
regression models accounted for the complex sampling
design of the NHIS via appropriate weighting (Proc Surveyl-
ogistic in SAS 9.2).
3. Results and Discussion
3.1. Results. The final sample included 7,088 individuals.
Overall, CRC screening was up to date in approximately
56% of respondents. Weighted CRC screening rates among
NHIS respondents were as follows: white males (58%), white
females (58%), black males (44%), black females (48%),
Hispanic males (39%), and Hispanic females (37%).
Table 1 presents several known predictors of CRC screen-
ing including both the unadjusted analysis and the anal-
ysis adjusted for main eﬀects only. In the adjusted anal-
yses, demographic variables significantly associated with
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Table 1: Colorectal cancer screening according to selected covariates (n = 7088).
Variable CRC screening rate (weighted) Unadjusted odds ratio [CI95] Adjusted odds ratio [CI95]1
Overall 55.8
Weight status
aNormal weight 56.3
Overweight 55.7 0.97 [0.86–1.11] 1.00 [0.84–1.21]
Obese 55.5 0.98 [0.85–1.12] 0.91 [0.75–1.12]
Gender
aFemale 55.7 0.99 [0.89–1.10] 0.86 [0.73–1.02]
Male 56.0
Race
aHispanic 38.2
Black 46.1 1.38 [1.06–1.81] 1.26 [0.87–1.82]
White 58.5 2.28 [1.85–2.80] 1.25 [0.96–1.63]
Age
a50–59 47.2
60–69 62.7 1.87 [1.67–2.11] 1.69 [1.41–2.02]
70–79 65.0 2.08 [1.79–2.41] 1.71 [1.39–2.10]
Marital status
aUnmarried 51.6
Married 57.5 1.27 [1.15–1.41] 1.02 [0.86–1.20]
Education
a<12 years 44.6
High school graduate 53.3 1.41 [1.21–1.70] 1.03 [0.83–1.28]
Some college 55.6 1.56 [1.32–1.84] 1.01 [0.79–1.29]
College graduate 65.3 2.33 [1.96–2.78] 1.42 [1.09–1.85]
Annual income
a<20K 45.0
>20K 58.0 1.69 [1.48–1.93] 1.31 [1.05–1.63]
Regular source of medical care2
aNo 28.5
Yes 57.4 3.38 [2.57–4.44] 1.11 [0.78–1.57]
Insured
aNo 22.7
Yes 57.9 3.78 [3.02–4.73] 1.57 [1.16–2.14]
Oﬃce visits in last year
aNone 24.4
One 43.3 2.37 [1.78–3.16] 1.21 [0.83–1.77]
2–5 visits 58.4 4.35 [3.39–5.59] 1.60 [1.14–2.27]
≥6 visits 64.9 5.74 [4.44–7.42] 2.05 [1.42–2.96]
Physician recommendation3
Yes 81.9 43.49 [36.82–51.36] 36.97 [31.18–43.84]
aNo 9.4
Health status
aFair/Poor 56.5
Excellent/Good 52.8 1.16 [1.01–1.33] 1.12 [0.91–1.38]
Comorbidities
a0 43.7
1 55.3 1.60 [1.38–1.85] 1.18 [0.94–1.48]
2-3 62.4 2.14 [1.85–2.48] 1.28 [0.99–1.65]
4-5 62.3 2.13 [1.73–2.62] 1.20 [0.85–1.70]
6 or more 73.4 3.55 [2.29–5.53] 2.28 [1.14–4.56]
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Table 1: Continued.
Variable CRC screening rate (weighted) Unadjusted odds ratio [CI95] Adjusted odds ratio [CI95]1
Personal history cancer ever
aNo 69.3
Yes 53.5 1.96 [1.67–2.30] 1.15 [0.92–1.43]
Alcohol consumption4
aHeavy 51.6
Light 59.1 1.23 [0.93–1.63] 1.01 [0.72–1.41]
None 54.0 0.91 [0.69–1.20] 1.03 [0.73–1.45]
Smoke
aCurrent 55.0
Former 62.6 2.28 [1.93–2.70] 1.27 [1.03–1.58]
Never 42.4 1.67 [1.43–1.94] 1.26 [1.03–1.54]
Recreational physical activity (METS)
aNone/unable to exercise 48.1
<675 59.4 1.58 [1.39–1.79] 0.97 [0.81–1.17]
≥675 69.9 1.84 [1.61–2.09] 1.19 [0.98–1.44]
aReference category
1Adjusted for all covariates listed in first column
2Recoded from NHIS data, has a usual place of care which is not the emergency room
3Saw physician in last 12 months and received a recommendation for either colonoscopy or endoscopy
4Heavy ≥14 drinks/week, light = 1–14 drinks/week
increased screening included age greater than 60, college
education, and higher income. Access variables positively
associated with CRC screening included being insured and
increasing number of doctor visits in the last year. A strong
association between physician recommendation and a CRC
screening was observed (OR 36.97, P < 0.001).
Obesity was categorized further as obesity class I, II,
and III, and there was no eﬀect (data not shown). This
classification could not be carried through in subgroups due
to sample size. We also examined endoscopy and FOBT
as separate outcomes and found no diﬀerences (data not
shown).
Table 2 addresses the hypothesis of this study and shows
the multivariable model for the relationship of weight status
and CRC which adjusted for the covariates in Table 1 as
well as interactions between weight status with gender
and race/ethnicity. There were no significant associations
between weight status and CRC screening in Hispanic men,
Hispanic women, black men, black women, white men, and
white women, with the gender by weight status and race/
ethnicity by weight status interactions not significant (P =
0.512 and 0.654, resp.).
3.2. Discussion. Obese and overweight individuals are as
likely to receive CRC screening as their normal weight peers
regardless of gender, race, or Hispanic ethnicity. This finding
contradicts other literature which suggests a relationship
between weight status and CRC screening. This study agrees
with the recent analysis of Chang et al., who found no
evidence that obese or overweight patients were less likely to
receive recommended care, including CRC screening, when
compared with their normal weight peers [11]. Our model
isolates the relationship of weight and CRC screening from
multiple known predictors and examines this relationship
more comprehensively by incorporating race, gender, and
ethnicity. Other work using smaller datasets may have been
unable to account for all potential covariates, and only very
large datasets could accommodate a subgroup analysis such
as this. Access to care is strongly associated with CRC screen-
ing. The strength of the association of physician recom-
mendation and CRC screening is striking and may indicate
that physician recommendation is necessary for screening.
The literature indicates that this eﬀect appears to persist
regardless of race and gender [9]. More work is needed
to understand barriers and predictors of physician recom-
mendation in subgroups who are at risk for not being
screened.
Findings presented here may be directly compared to
a recent analysis which also examined the relationship of
obesity and CRC screening in the NHIS 2005 data set [10]. In
contrast to our findings, these authors found that obese white
women were less likely to screen. Our analysis is distinct
in several ways. First, we included any individual who had
complete data for either the set of questions for FOBT or
for endoscopy. So, for example, individuals who were up to
date on endoscopy were counted as up to date for colorectal
cancer screening, regardless of missing data on FOBT and
vice versa. While this is not the convention in handling of
missing data, the population that would have been excluded
from our analysis (if we required complete data for both
sets of questions) was distinct in screening behavior and
several known predictors of screening. Second, we separated
Hispanics from the white and black subgroups. We believed
that this group warranted separate consideration because of
the low rate of screening in Hispanics and the relative lack
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Table 2: Adjusted model for colorectal cancer screening according
to race/gender and ethnicity (n = 7088).
Weight status
CRC
screening rate
Adjusted
odds ratios1
95% confidence
interval
Stratum specific
for race/gender
White males
(n = 2491) 58.6
Normal 59.7 1.00
Overweight 57.9 0.90 0.68–1.18
Obese 59.0 0.83 0.61–1.13
Black males
(n = 392) 43.8
Normal 45.5 1.00
Overweight 44.2 1.07 0.62–1.85
Obese 42.1 1.06 0.56–2.02
Hispanic males
(n = 323) 39.4
Normal 37.6 1.00
Overweight 35.0 0.71 0.37–1.37
Obese 52.1 0.97 0.47–2.03
White females
(n = 2955) 58.3
Normal 58.3 1.00
Overweight 59.9 1.11 0.84–1.46
Obese 56.5 0.91 0.68–1.21
Black females
(n = 496) 48.0
Normal 36.2 1.00
Overweight 53.6 1.32 0.75–2.31
Obese 48.1 1.16 0.64–2.10
Hispanic females
(n = 431) 37.1
Normal 32.6 1.00
Overweight 34.6 0.88 0.47–1.64
Obese 43.3 1.06 0.54–2.10
1
Adjusted for all variables in Table 1, as well as interaction terms of race,
gender, and Hispanic ethnicity.
of literature on barriers to screening in this group. Also, our
analysis reports on men. Finally, this analysis is distinct in
that it isolates the overweight group from the normal weight
group. Table 2 supports this decision and shows that the
rate of CRC screening in overweight individuals is distinct
from both the normal weight group and the obese group in
several of our subgroups. For example, the rate of screening
in overweight black females is 54%, compared to 36% in
normal weight black females and 48% in obese black females.
Black females do not see themselves as overweight until a
higher BMI, compared to their white counterparts, and this
may explain the diﬀerence between overweight and obese
[15].
The cross-sectional design of our study precludes deter-
mination of cause. BMI and CRC screening are self-reported
and therefore may be distorted. Sample size is a challenge in
analysis of our subgroups. Although all cells met the NHIS
suggested requirements (less than 30% standard error), the
wide confidence intervals suggest that sample size may have
been a restriction in groups such as Hispanics. Additionally,
we could not examine subclasses of obesity (i.e., obesity I, II,
III) in our groups of interest due to sample size.
CRC screening reduces mortality and prevents colorectal
cancer. However, rates of screening are unacceptably low
overall and in minority subgroups. The rising prevalence of
obesity and the higher burden of cancer risk in obese individ-
uals make this an especially important population subgroup
in terms of race/ethnicity, gender, and other characteristics.
4. Conclusions
There is no relationship between increasing weight and
CRC screening in this nationally representative sample.
Regardless of the lack of association of obesity and CRC
screening, obesity remains a risk factor for increased mor-
bidity/mortality related to CRC. Therefore, future work is
needed to understand and mitigate risk in the obese pop-
ulation especially as this group comes to represent an ever-
increasing percentage of the US population.
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